SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SI-BONE, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$19.66−0.02 (-0.10%)
Close on Oct 19, 2026
- Market cap
- $874.42M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
+$4.92 (+33.38%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
SI-BONE, Inc. grew revenue 15.3% to $213.60M over the twelve months to Jun 30, 2026. Free cash flow was -$4.39M.
Revenue
$213.60M
+15.3% vs. a year earlier
Operating income
-$17.75M
TTM Q2 2026
Free cash flow
-$4.39M
TTM Q2 2026
EPS, diluted
-$0.34
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $874.42M
- P/E ratio
- –
- Price to sales
- 4.09
- Price to book
- 4.80
- Dividend yield
- 0.00%
- Free cash flow yield
- -0.50%
Fundamentals
- Revenue
- $213.60M
- Net income
- -$14.63M
- EPS, diluted
- -$0.34
- Free cash flow
- -$4.39M
- Book value per share
- $4.10
- Diluted shares
- 44M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$213.60M+15.3% YoY
Gross profit
$169.87M+15.4% YoY
Operating income
-$17.75M
Net income
-$14.63M
EPS, diluted
-$0.34
Free cash flow
-$4.39M
Reported periodTrailing twelve months